In contrast to the high UBE2C+ tumour cells score group, the low UBE2C+ tumour cells score group exhibited a higher proportion of B cells memory and T cells CD4 memory activated, and a lower proportion of Macrophages M2 and Monocytes, suggesting that the low UBE2C+ tumour cells score group may have better anti‐tumour immune effects and less immunosuppression. The gene discussed is UBE2C; the disease is neoplasm.